RheumaView · Chapter 14 · Patient guide
Osteoporosis and fracture prevention in r-axSpA: why extra bone formation does not necessarily mean strong bones
Radiographic axial spondyloarthritis (r-axSpA) can create an apparent contradiction.
In this chapter
- Two opposite-looking bone processes can happen at the same time
- Check your understanding 1
- What is osteoporosis?
- Why is osteoporosis important in r-axSpA?
- Why does ankylosis make fracture risk different?
- Not every fracture in r-axSpA is simply an “osteoporosis fracture”
- What is a DXA scan?
- Why can spine DXA be misleading in advanced r-axSpA?
- Check your understanding 2
- Does that mean lumbar DXA is useless?
- Why is the hip measurement useful?
- Are there other ways to assess bone?
- What do T-scores and Z-scores mean?
- A fracture can matter more than the DXA number
- Vertebral fractures can be silent
- “My back is more stooped. Is that a compression fracture?”
- What is FRAX?
- FRAX was not designed specifically for r-axSpA
- Check your understanding 3
- Who should be considered for bone-health assessment?
- Why inflammation itself matters to bone
- Does a biologic improve bone density?
- Long-term systemic steroids deserve caution
- What can you do to protect bone?
- Calcium: more is not automatically better
- Vitamin D
- Check your understanding 4
- Weight-bearing exercise helps—but the safest type depends on the spine
- “If my bones are weak, should I avoid exercise?”
- Fall prevention is fracture prevention
- Why falls are especially important in advanced ankylosis
- Forceful spinal manipulation is not fracture prevention
- What if I fall but initially feel okay?
- What if the first X-ray is normal?
- How is the need for osteoporosis medicine decided?
- Osteoporosis medication and r-axSpA medication solve different problems
- A previous fracture changes the conversation
- Vertebral fracture assessment can be useful even without dramatic pain
- The “normal DXA” trap
- Check your understanding 5
- Questions to ask about bone health
- The key message
- Where to go next
- Selected evidence sources
An X-ray may show:
- syndesmophytes;
- bony bridges;
- ligament ossification;
- or extensive spinal fusion.
The spine may appear to be producing extra bone.
Yet the same person can also have osteoporosis or reduced bone strength.
How can both be true?
Because these are different biological processes.
New bone formation around the spine does not necessarily mean that the bone inside the vertebrae is strong.
In advanced r-axSpA, the combination of:
reduced bone strength + a rigid ankylosed spine
can substantially increase the consequences of a fall or even relatively minor trauma.
Bone health therefore deserves its own place in long-term r-axSpA care.
Two opposite-looking bone processes can happen at the same time
Axial SpA can affect the skeleton in more than one way.
New bone formation
Inflammation and abnormal repair around:
- vertebral corners;
- entheses;
- ligaments;
- and joints
can produce:
- syndesmophytes;
- bridging;
- ankylosis;
- and ligamentous ossification.
This makes parts of the spine look increasingly dense or fused on an X-ray.
Loss of bone strength
At the same time, chronic inflammation, reduced mobility and other factors can contribute to loss of bone mineral and deterioration in bone structure.
The vertebra can therefore become more fragile internally even while extra bone forms around its edges.
That is the paradox:
The spine can become more rigid without becoming stronger.
Check your understanding 1
An X-ray shows extensive syndesmophytes and spinal fusion.
Does that prove that osteoporosis is impossible?
No.
Those X-ray findings represent new bone formation and structural ankylosis.
They do not measure the strength of the trabecular bone inside the vertebrae.
What is osteoporosis?
Osteoporosis is a skeletal condition in which bone strength is reduced enough to increase fracture risk.
Bone strength depends on more than simply the amount of calcium visible on an image.
It reflects:
- bone mineral density;
- internal bone architecture;
- bone turnover;
- age;
- previous fractures;
- medical conditions;
- medications;
- and other risk factors.
Osteoporosis is often silent until a fracture occurs.
That is why screening and risk assessment can matter even when a person has no bone pain.
Why is osteoporosis important in r-axSpA?
People with ankylosing spondylitis/r-axSpA have an increased risk of osteoporosis and particularly vertebral fractures compared with the general population.
The 2026 ACR summary recommends considering DXA screening for low bone mass and strongly recommends evaluation and counseling about falls. Screening needs to account for both ordinary osteoporosis risks and the structural changes of axSpA. [S01]
The risk is not explained by one mechanism.
Several factors may contribute:
- chronic inflammation;
- reduced physical activity;
- decreased mechanical loading;
- structural spinal disease;
- reduced balance;
- smoking;
- vitamin D deficiency;
- age;
- glucocorticoid exposure when present;
- and ordinary osteoporosis risk factors unrelated to axSpA.
Why does ankylosis make fracture risk different?
A flexible spine contains many motion segments.
Those segments help distribute forces.
When multiple vertebrae become fused, the spine behaves more like a long rigid lever.
A rigid lever can transmit force across a much larger segment.
If the underlying bone is also fragile, the combination becomes particularly important:
rigidity + reduced bone strength = greater vulnerability to fracture.
This helps explain why a fracture in an ankylosed spine can occur after trauma that seems relatively minor.
Not every fracture in r-axSpA is simply an “osteoporosis fracture”
This distinction matters.
Fractures in advanced r-axSpA reflect both:
Bone strength
Osteoporosis or impaired bone quality may make the vertebra easier to fracture.
Spinal biomechanics
Ankylosis changes how forces travel through the spine.
Therefore, fracture prevention is not only:
“Improve the DXA score.”
It also includes:
- fall prevention;
- safe movement;
- awareness after trauma;
- maintaining strength and balance;
- and recognizing when new focal pain requires imaging.
What is a DXA scan?
DXA, sometimes written DEXA, stands for dual-energy X-ray absorptiometry.
It is the standard test used to measure bone mineral density.
Common measurement sites include:
- lumbar spine;
- total hip;
- femoral neck.
The test is quick and uses a low dose of radiation.
For most people, DXA is an extremely useful tool.
But r-axSpA creates a special problem.
Why can spine DXA be misleading in advanced r-axSpA?
A standard lumbar DXA scan measures everything dense within its projected region.
In advanced r-axSpA that region may contain:
- syndesmophytes;
- bony bridging;
- ligament ossification;
- degenerative osteophytes;
- and other extra bone.
Those structures can make the lumbar-spine measurement look artificially high.
So a report may show:
“Normal lumbar bone density”
even though the internal vertebral bone is not necessarily normal.
This is one of the most important limitations of DXA in advanced radiographic disease.
Check your understanding 2
A patient with extensive syndesmophytes has:
Lumbar spine DXA: normal
Does that prove low fracture risk?
No.
Extra spinal bone can increase the measured density and make the lumbar result appear reassuring.
The hip measurement, fracture history, structural disease and other risk factors still matter.
Does that mean lumbar DXA is useless?
No. Lumbar DXA still provides useful information, especially before extensive new bone formation or other artifacts develop. The interpreter should inspect the images and identify vertebrae that are unsuitable for measurement.
For adults with syndesmophytes or spinal fusion, the 2026 ACR summary conditionally recommends DXA of both the spine and hips, rather than the hip alone. This does not remove the need to recognize falsely elevated lumbar results. The result should be interpreted with fracture history and the technical quality of each measured site. [S01, S13]
Why is the hip measurement useful?
The hip is generally less affected by syndesmophytes and spinal ligament ossification.
Hip or femoral-neck bone density can therefore provide useful information when the lumbar spine is difficult to interpret.
But it also has limitations.
Some patients with axSpA are relatively young.
Bone loss may not be fully reflected at the hip early in the disease.
And fracture risk in an ankylosed spine involves more than hip BMD alone.
So:
A normal hip DXA does not automatically eliminate all fracture concern in advanced r-axSpA.
Are there other ways to assess bone?
In selected situations, clinicians may use additional tools.
These can include:
Vertebral imaging
To determine whether a vertebral compression fracture has already occurred.
Vertebral fracture assessment — VFA
Some DXA machines can obtain a low-radiation lateral image of the spine to look for vertebral deformities.
Trabecular bone score — TBS
This uses information from the DXA image to estimate aspects of bone texture or microarchitecture.
Quantitative CT
CT-based techniques can measure bone in three dimensions and may avoid some of the distortion caused by syndesmophytes.
These tools can be helpful in selected cases.
They are not necessary for everyone.
And none replaces clinical assessment of fracture risk.
What do T-scores and Z-scores mean?
A DXA report may contain one or both.
T-score
This compares density with a healthy young-adult reference population. Standard T-score diagnostic classification applies to postmenopausal women and men aged 50 or older. A T-score of −2.5 or below at a valid lumbar-spine, total-hip or femoral-neck site meets the densitometric definition of osteoporosis. In specified circumstances a forearm site is used. A technically distorted spine result is not a reliable reassurance. [S13]
Z-score
This compares density with an age- and sex-matched reference population. Z-scores are preferred for women before menopause and men under 50. Z ≤ −2.0 means “below the expected range for age”; it does not automatically diagnose osteoporosis. In younger people, fracture history, possible secondary causes and clinical context matter particularly. [S13]
Neither score measures every aspect of bone quality or the way a fused spine transmits force.
A fracture can matter more than the DXA number
A person may have a fracture even when DXA does not reach the traditional osteoporosis threshold.
That is not unusual in osteoporosis medicine.
Fracture risk depends on:
bone density + bone quality + falls + biomechanics + clinical risk factors.
In r-axSpA, spinal ankylosis adds another biomechanical factor that an ordinary DXA score cannot capture.
Therefore:
A clinically important fragility fracture should not be dismissed because the DXA result does not “look bad enough.”
Vertebral fractures can be silent
Not every vertebral fracture causes dramatic acute pain.
Some vertebral compression fractures are discovered incidentally.
Possible clues can include:
- unexpected height loss;
- increasing thoracic kyphosis;
- new localized pain;
- or a vertebral deformity noted on imaging obtained for another reason.
But r-axSpA makes this more complicated because the disease itself can alter posture and spinal shape.
So an apparent change in posture should not automatically be labeled osteoporosis.
Comparison with previous imaging can be very useful.
“My back is more stooped. Is that a compression fracture?”
Maybe—but not necessarily.
Possible explanations include:
- structural kyphosis from r-axSpA;
- degenerative spinal change;
- vertebral compression fracture;
- muscle weakness;
- posture;
- or a combination.
This is another reason serial clinical observation and comparison with previous imaging matter.
What is FRAX?
FRAX is a tool that estimates the 10-year probability of:
- major osteoporotic fracture;
- and hip fracture.
It uses factors such as:
- age;
- sex;
- weight and height;
- previous fracture;
- smoking;
- glucocorticoid use;
- rheumatoid arthritis;
- alcohol;
- family history;
- and optionally femoral-neck bone density.
FRAX is useful in general osteoporosis care.
But there is an important limitation in axSpA.
FRAX was not designed specifically for r-axSpA
FRAX combines selected clinical risks, with or without femoral-neck bone density, to estimate ten-year fracture probability in the populations and ages for which it is validated. It does not directly include syndesmophytes, spinal ankylosis, axSpA activity or altered spinal mechanics. A relatively young person can have a low ten-year estimate despite clinically important concerns. [S33]
That does not establish that FRAX underestimates risk in every person with r-axSpA. It means the clinician must interpret the result alongside prior fractures, falls, spine structure and other risks. Do not select the rheumatoid arthritis checkbox simply because you have r-axSpA: these are different diagnoses. There is no universal patient-applied correction factor for r-axSpA.
Check your understanding 3
A 48-year-old man with longstanding r-axSpA has:
- extensive spinal ankylosis;
- a previous low-trauma vertebral fracture;
- but a relatively low conventional FRAX score.
Which matters more?
The clinician should not dismiss the fracture history because the FRAX percentage appears low.
FRAX is one tool.
The actual fracture and the axSpA-specific biomechanics carry important clinical information.
Who should be considered for bone-health assessment?
There is no single age cutoff that captures every patient with r-axSpA.
Risk assessment becomes especially relevant when there is:
- longstanding disease;
- substantial syndesmophyte formation or spinal fusion;
- previous low-trauma fracture;
- unexplained vertebral deformity;
- osteoporosis risk factors;
- prolonged systemic glucocorticoid exposure;
- smoking;
- low body weight;
- significant immobility;
- vitamin D deficiency risk;
- older age;
- menopause;
- family history of osteoporosis or hip fracture;
- recurrent falls;
- or other conditions affecting bone.
Current U.S. rheumatology guidance conditionally recommends screening adults with ankylosing spondylitis for osteopenia/osteoporosis with DXA.
The exact timing should be individualized.
Why inflammation itself matters to bone
Bone is constantly remodeled.
Old bone is removed and new bone is formed.
Inflammatory cytokines can disturb that balance and increase bone resorption.
This means active inflammatory disease may contribute to systemic bone loss even while local repair around the spine produces new bone.
Again, both processes can coexist:
local new bone formation + generalized bone loss.
Controlling inflammatory disease is therefore part of good bone-health management.
But treatment of axSpA does not automatically replace osteoporosis evaluation or treatment when those are needed.
Does a biologic improve bone density?
Targeted control of inflammation can improve bone turnover and bone mineral density in many patients.
That is encouraging.
But an improved DXA measurement does not necessarily erase:
- established ankylosis;
- previous fracture risk;
- fall risk;
- or the altered biomechanics of a fused spine.
Bone health and axSpA disease control overlap.
They are not identical treatment problems.
Long-term systemic steroids deserve caution
Long-term systemic glucocorticoids are generally not recommended for predominantly axial disease.
They can also contribute to osteoporosis.
That is another reason chronic prednisone-type therapy is usually a poor long-term strategy for pure axial inflammation.
Occasional or local steroid use in other clinical circumstances is a different question.
When significant systemic glucocorticoid exposure is necessary for another condition, fracture risk deserves additional attention.
What can you do to protect bone?
Fracture prevention usually combines several approaches.
1. Keep inflammatory disease appropriately controlled
Persistent systemic inflammation can adversely affect bone.
2. Stay physically active
Appropriate activity supports:
- muscle strength;
- balance;
- bone loading;
- cardiovascular health;
- and independence.
For bone health, weight-bearing and resistance exercise are especially useful.
But the program must match structural risk.
3. Build strength
Stronger leg and trunk muscles can improve:
- function;
- balance;
- ability to recover from a stumble;
- and confidence with movement.
Strength is an important component of fall prevention.
4. Train balance when needed
For someone with advanced ankylosis or previous falls, balance work may be just as important as stretching.
5. Avoid smoking
Smoking adversely affects bone health and is also associated with worse structural outcomes in axial SpA.
6. Avoid excessive alcohol
Heavy alcohol use increases fall and fracture risk and can negatively affect bone health.
7. Maintain adequate nutrition
Bone health requires adequate:
- calcium;
- vitamin D;
- protein;
- and overall nutrition.
Supplements are not automatically necessary when dietary intake is adequate.
Calcium: more is not automatically better
Calcium supports bone health, but the goal is adequate total intake, preferably from food when practical. Supplements fill a gap; they do not replace a balanced diet or osteoporosis treatment.
For the older-adult population addressed by the US BHOF guide, the daily total is 1,000 mg for men aged 50–70 and 1,200 mg for women aged 51 or older and men aged 71 or older. These totals include food and any supplements. Other ages, countries and clinical circumstances can have different recommendations. [S33]
Ask about your own target, especially with kidney disease, kidney stones or prescribed calcium/vitamin D treatment. More supplemental calcium is not automatically better.
Vitamin D
Vitamin D helps the body absorb calcium and supports bone health.
People at risk of deficiency may need:
- blood testing;
- dietary attention;
- or supplementation.
General osteoporosis guidance often uses vitamin D supplementation when needed to achieve adequate levels, particularly in people with known or suspected metabolic bone disease.
But:
Vitamin D is not an osteoporosis medication by itself.
Correcting deficiency is important.
It does not substitute for appropriate osteoporosis treatment in someone at high fracture risk.
Check your understanding 4
Which strategy best protects bone?
A
Take very large calcium and vitamin D doses and ignore everything else.
B
Control inflammation, assess fracture risk, exercise safely, maintain adequate nutrition, reduce falls, avoid smoking/excess alcohol, and use osteoporosis medication when indicated.
Answer: B.
Bone health is a system, not a supplement.
Weight-bearing exercise helps—but the safest type depends on the spine
Walking, stair climbing and other weight-bearing activities provide skeletal loading.
Resistance exercise also supports bone and muscle.
For many patients these are beneficial.
But high-impact activity is not automatically appropriate in someone with:
- severe osteoporosis;
- previous vertebral fracture;
- extensive spinal ankylosis;
- poor balance;
- or high fall risk.
In that situation, lower-impact weight-bearing exercise plus controlled resistance and balance training may be safer.
“If my bones are weak, should I avoid exercise?”
Usually, no.
Complete inactivity can worsen:
- muscle weakness;
- balance;
- conditioning;
- and bone health.
The better approach is:
adapt the exercise rather than abandon movement.
A physical therapist or exercise professional familiar with osteoporosis and spinal ankylosis can help when fracture risk is significant.
Fall prevention is fracture prevention
Many fractures follow a fall. A severely fragile vertebra can also fracture under ordinary daily loading, without a remembered fall. Preventing falls remains particularly important when the spine is rigid and transfers force differently.
Consider risk factors such as:
- poor balance;
- leg weakness;
- dizziness;
- sedating medications;
- low blood pressure;
- poor vision;
- unsafe footwear;
- loose rugs;
- poor lighting;
- stairs;
- ice;
- pets underfoot;
- and environmental obstacles.
Fall prevention may sound mundane compared with biologics and imaging.
It can be one of the most practical ways to prevent a serious injury.
Why falls are especially important in advanced ankylosis
For a person with a flexible spine, a fall may produce only soft-tissue pain.
For someone with a rigid ankylosed spine, the same fall can transmit force differently.
Therefore a patient with advanced r-axSpA may need to think about:
- balance;
- safe footwear;
- winter conditions;
- home hazards;
- and fall prevention
more seriously than someone with early disease and preserved spinal mobility.
Forceful spinal manipulation is not fracture prevention
Forceful manipulation cannot reverse ankylosis or improve bone strength. The ACR 2026 summary strongly recommends against spinal manipulation in adults with axSpA. Work with a clinician or physiotherapist on safe strength, balance, posture and mobility within your actual range. [S01]
What if I fall but initially feel okay?
New neck or back pain after a fall or injury deserves particular concern when the spine is fused or markedly stiff. Seek emergency assessment for a suspected spinal injury. Avoid unnecessary movement; do not let someone forcibly straighten a fixed deformity. Tell the emergency team about your usual spinal position. [S02, S12]
Pain can become apparent after the initial event. If new or persistent neck/back pain develops, do not assume that feeling well immediately after the fall excluded injury. The new-pain guide explains warning signs and why additional imaging may be required.
What if the first X-ray is normal?
In an ankylosed spine, routine X-rays can sometimes miss fracture.
If clinical concern remains, CT and/or MRI may be necessary.
This is why the clinician needs to know about:
- spinal ankylosis;
- osteoporosis;
- previous fracture;
- and the change from baseline.
How is the need for osteoporosis medicine decided?
A diagnosis of osteoporosis or a previous fragility fracture should lead to a treatment discussion. Medication is often recommended when fracture risk is high; lifestyle measures alone may be insufficient. In postmenopausal women and men aged 50 or older, the BHOF guide includes a valid T-score ≤ −2.5 and a previous hip or vertebral fracture among treatment indications. Other fractures and FRAX can also guide decisions. Thresholds vary by country and clinical setting. [S33]
The 2026 ACR summary supports adding an osteoporosis medicine when an adult with axSpA has osteoporosis; targeted axSpA treatment alone should not be assumed to address it. Selection depends on fracture pattern and risk, kidney function, other conditions, previous treatment and reproductive plans. Ask about duration, monitoring and how any future change or discontinuation will be managed. [S01]
Osteoporosis medication and r-axSpA medication solve different problems
This distinction is worth stating clearly.
Targeted axSpA treatment
Primarily controls inflammatory disease.
Osteoporosis treatment
Primarily reduces skeletal fragility and fracture risk.
Some effects overlap indirectly because controlling inflammation may benefit bone metabolism.
But one does not automatically replace the other.
A person may appropriately need both.
A previous fracture changes the conversation
A fracture is not merely an event that heals and disappears from the medical history.
A previous fracture can indicate increased risk of another fracture.
General osteoporosis guidance emphasizes that adults with a recent fracture deserve systematic evaluation for bone fragility and secondary prevention.
For r-axSpA, a spinal fracture is especially important because the altered biomechanics may remain.
After recovery, the long-term plan may need to include:
- bone-health assessment;
- osteoporosis treatment when indicated;
- rehabilitation;
- balance work;
- fall prevention;
- and review of activity risk.
Vertebral fracture assessment can be useful even without dramatic pain
Some vertebral fractures produce little acute pain.
In selected patients, clinicians may consider vertebral imaging if there is:
- unexplained height loss;
- suggestive deformity;
- osteoporosis;
- previous fractures;
- or other substantial risk factors.
The exact test depends on the situation.
Again, not every change in spinal shape in r-axSpA represents osteoporosis.
Comparison with prior imaging is valuable.
The “normal DXA” trap
One of the most useful lessons from this article is:
Normal DXA does not always equal normal fracture risk in r-axSpA.
This is particularly relevant when there is:
- extensive syndesmophyte formation;
- spinal fusion;
- altered biomechanics;
- or a previous fracture.
The DXA report is one piece of evidence.
The clinician must interpret it alongside the structural disease.
Check your understanding 5
Patient A
Mild r-axSpA, preserved spinal mobility, no fractures, normal hip and spine DXA.
Interpretation
Reassuring overall, while ordinary risk-factor management still applies.
Patient B
Extensive spinal ankylosis, “normal” lumbar DXA, low femoral-neck BMD.
Interpretation
The lumbar value may be artificially increased by spinal ossification. Bone-health risk deserves closer assessment.
Patient C
Extensive ankylosis, apparently normal DXA, previous low-trauma vertebral fracture.
Interpretation
The fracture history is highly important despite the apparently reassuring DXA.
Questions to ask about bone health
You may want to ask:
- Should I have a DXA scan?
- Does my degree of spinal ankylosis affect how the DXA should be interpreted?
- What does my hip bone density show?
- Could syndesmophytes make my lumbar bone density appear artificially high?
- Do I need vertebral fracture assessment or other spine imaging?
- Have I lost height compared with previous visits?
- Is FRAX useful in my situation, and what are its limitations?
- Do I have osteoporosis risk factors unrelated to axSpA?
- Should my vitamin D level be checked?
- Am I getting enough calcium from my diet?
- Does my exercise program need modification because of fracture risk?
- Do I need balance or fall-prevention training?
- Does my fracture history justify osteoporosis medication?
- Should someone specifically manage my bone health?
The key message
r-axSpA can produce two apparently opposite skeletal changes:
extra bone formation around the spine
and
loss of bone strength within the skeleton.
The result can be a spine that is:
more rigid but not necessarily stronger.
That is why fracture prevention requires more than looking at an X-ray or one DXA number.
A useful assessment considers:
bone density
previous fractures
spinal ankylosis
falls
inflammation
medications
nutrition
physical activity
and
other osteoporosis risk factors.
The goal is not simply to improve a bone-density score.
The goal is to prevent fractures while maintaining safe movement, strength, independence and long-term function.
Where to go next
- Spinal structural changes
- Exercise and physical therapy
- New spinal pain and injury
- Everyday life
- Prepare for a visit
- Back to the patient guide
Selected evidence sources
S01. American College of Rheumatology / Spondylitis Association of America / SPARTAN. 2026 axial spondyloarthritis guideline summary. Posted June 24, 2026. Source.
S02. Ramiro S, et al. ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update. Ann Rheum Dis. 2023;82:19–34. doi:10.1136/ard-2022-223296. Source.
S12. NICE. Spinal injury: assessment and initial management. NG41. Source.
S13. International Society for Clinical Densitometry. Official Adult Positions, 2023. Source.
S33. LeBoff MS, et al. The clinician’s guide to prevention and treatment of osteoporosis. Osteoporos Int. 2022;33:2049–2102. doi:10.1007/s00198-021-05900-y. Bone Health and Osteoporosis Foundation. Source.
Sources checked: October 1, 2026. Examples and checkpoints are fictional educational scenarios.
Educational information only. This article supports discussion with your clinicians and does not give an individual diagnosis or medication prescription.